
Danaher Corporation DHR
$ 198.94
0.21%
Annual report 2025
added 02-24-2026
Danaher Corporation Operating Expenses 2011-2026 | DHR
Annual Operating Expenses Danaher Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | 6.71 B | 7.7 B | 7.17 B | 6.58 B | 7.29 B | 7.01 B | 6.68 B | 6.32 B | 5.63 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 7.7 B | 5.63 B | 6.79 B |
Operating Expenses of other stocks in the Diagnostics research industry
| Issuer | Operating Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
58 M | - | -6.23 % | $ 30.6 M | ||
|
Agilent Technologies
A
|
1.99 B | $ 121.37 | 0.83 % | $ 36.9 B | ||
|
Burning Rock Biotech Limited
BNR
|
726 M | $ 20.3 | 2.06 % | $ 218 M | ||
|
Aspira Women's Health
AWH
|
13.8 M | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
21.6 M | - | -13.05 % | $ 7.29 M | ||
|
Check-Cap Ltd.
CHEK
|
14.1 M | - | - | $ 9.42 M | ||
|
Chembio Diagnostics
CEMI
|
28.5 M | - | 0.22 % | $ 16.8 M | ||
|
CareDx, Inc
CDNA
|
411 M | $ 17.75 | 0.68 % | $ 946 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
59.4 M | - | - | $ 562 M | ||
|
DermTech
DMTK
|
104 M | - | -11.32 % | $ 2.94 M | ||
|
Akumin
AKU
|
778 M | - | -17.87 % | $ 25.9 M | ||
|
Enzo Biochem
ENZ
|
47.4 M | - | -8.98 % | $ 14.8 K | ||
|
Co-Diagnostics
CODX
|
50.6 M | $ 1.39 | 0.72 % | $ 1.85 M | ||
|
Exact Sciences Corporation
EXAS
|
2.47 B | - | - | $ 19.8 B | ||
|
Accelerate Diagnostics
AXDX
|
77.2 M | - | -61.36 % | $ 2.46 M | ||
|
Castle Biosciences
CSTL
|
59.5 M | $ 24.59 | 0.91 % | $ 683 M | ||
|
Global Cord Blood Corporation
CO
|
451 M | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
134 M | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
5.91 M | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
983 M | - | 0.12 % | $ 80.1 M | ||
|
Charles River Laboratories International
CRL
|
607 M | $ 183.31 | 2.23 % | $ 9.09 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
585 M | - | - | $ 10.7 B | ||
|
Medpace Holdings
MEDP
|
118 M | $ 521.18 | 0.23 % | $ 15 B | ||
|
Interpace Biosciences
IDXG
|
20 M | $ 2.2 | - | $ 9.73 M | ||
|
Heska Corporation
HSKA
|
131 M | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
24.1 M | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
3.69 B | $ 131.54 | 0.94 % | $ 20.9 B | ||
|
NeoGenomics
NEO
|
430 M | $ 8.63 | 3.35 % | $ 1.11 B | ||
|
Natera
NTRA
|
258 M | $ 211.22 | -1.59 % | $ 20.8 B | ||
|
Fulgent Genetics
FLGT
|
181 M | $ 16.2 | 1.15 % | $ 490 M | ||
|
Koninklijke Philips N.V.
PHG
|
7.12 B | $ 29.12 | 0.12 % | $ 20 B | ||
|
Motus GI Holdings
MOTS
|
18.6 M | - | -34.28 % | $ 263 K | ||
|
Guardant Health
GH
|
226 M | $ 85.92 | -0.56 % | $ 10.8 B | ||
|
QIAGEN N.V.
QGEN
|
821 M | - | - | $ 10.6 B | ||
|
Myriad Genetics
MYGN
|
964 M | $ 5.14 | 4.58 % | $ 476 M | ||
|
Anixa Biosciences
ANIX
|
9.98 M | $ 2.8 | -2.95 % | $ 90.9 K | ||
|
Biomerica
BMRA
|
5.64 M | $ 2.11 | 0.48 % | $ 4.85 M | ||
|
Senseonics Holdings
SENS
|
61.8 M | $ 6.85 | 1.48 % | $ 286 M | ||
|
ICON Public Limited Company
ICLR
|
408 M | $ 113.78 | 0.64 % | $ 9.38 B | ||
|
Laboratory Corporation of America Holdings
LH
|
1.87 B | $ 268.92 | 0.03 % | $ 22.4 B | ||
|
Soleno Therapeutics
SLNO
|
181 M | $ 52.61 | -0.03 % | $ 2.67 B | ||
|
Celcuity
CELC
|
172 M | $ 119.5 | -1.12 % | $ 5.59 B | ||
|
Neogen Corporation
NEOG
|
1.48 B | $ 9.49 | -1.25 % | $ 2.06 B | ||
|
Lantheus Holdings
LNTH
|
123 M | $ 83.07 | 0.4 % | $ 5.61 B | ||
|
Neuronetics
STIM
|
104 M | $ 1.43 | -0.35 % | $ 94.3 M | ||
|
Quest Diagnostics Incorporated
DGX
|
1.46 B | $ 192.82 | -0.63 % | $ 21.4 B | ||
|
ENDRA Life Sciences
NDRA
|
5.76 M | $ 5.05 | 1.81 % | $ 3.97 M | ||
|
Thermo Fisher Scientific
TMO
|
7.15 B | $ 527.38 | 0.02 % | $ 199 B | ||
|
Trinity Biotech plc
TRIB
|
28.3 M | $ 0.71 | -0.27 % | $ 61.9 M |